Target intelligence / Profile preview

Cytokine (inflammatory)

Molecular classification
Cytokine, Signaling protein, Immunomodulator, Sometimes function through "Receptor–ligand" pairs (e.g., IL-6 receptor, TNF receptor)
01

Overview

Inflammatory cytokines are a broad class of small secreted proteins produced predominantly by immune cells (macrophages, T cells, dendritic cells) that mediate immune responses, inflammation, cell proliferation, and apoptosis. They include interleukins (e.g., IL-1, IL-6, IL-17), tumor necrosis factors (TNF-α), interferons (IFN-γ), chemokines, and colony-stimulating factors. Cytokines operate through binding to specific receptors on target cells and activating intracellular signaling pathways, principally the JAK-STAT, NF-κB, and MAPK pathways[4][8]. Persistent or dysregulated cytokine activity underlies many chronic inflammatory and autoimmune diseases, and cytokines are thus major therapeutic targets in pathological conditions like rheumatoid arthritis, IBD, psoriasis, and cancer[2][7][8]. Drugs targeting inflammatory cytokines are effective in controlling disease, but pose risks of immunosuppression and related safety concerns.

Other names
Inflammatory cytokinespro-inflammatory cytokinesimmune modulatorsimmunomodulatory cytokines
02

Mechanism of action

Cytokine neutralization (binding cytokines and preventing receptor interaction). Cytokine receptor blockade. Signaling pathway inhibition (e.g., JAK-STAT pathway inhibitors). Suppression of cytokine production.

03

Biological functions

Immune responseSignal transductionRegulation of inflammation (both initiation and resolution)Cell proliferationApoptosisCell activation and differentiation
04

Disease associations

InflammationAutoimmune diseaseCancerCardiovascular diseaseDiabetesNeurodegenerative diseaseInfectious disease
05

Safety considerations

Increased risk of infection (immunosuppression)Cytokine release syndromeOff-target effects (due to broad modulation of immune system)Autoimmunity or loss of immune tolerance
06

Interacting drugs

Monoclonal antibodies (e.g., infliximab, adalimumab, tocilizumab)

2 more in the full profile.

07

Biomarkers

Serum levels of TNF-α, IL-6, IL-1β, CRP (C-reactive protein, secondary marker)Circulating cytokine panels in autoimmune or inflammatory disease

Beyond the preview

Go deeper on Cytokine (inflammatory).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytokine (inflammatory).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call